Personal tools

MCL coexpression mm9:2348: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 6: Line 6:
|ontology_enrichment_disease=
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0004177!7.47e-11!29;UBERON:0005057!7.47e-11!29;UBERON:0000153!3.20e-10!43;UBERON:0002370!4.62e-09!23;UBERON:0000974!4.62e-09!23;UBERON:0004807!4.62e-09!23;UBERON:0005058!4.62e-09!23;UBERON:0003351!4.62e-09!23;UBERON:0009113!4.62e-09!23;UBERON:0003295!4.62e-09!23;UBERON:0009722!4.62e-09!23;UBERON:0005562!4.62e-09!23;UBERON:0007690!4.62e-09!23;UBERON:0000065!1.12e-08!41;UBERON:0000077!1.26e-08!35;UBERON:0003408!1.59e-08!24;UBERON:0006562!2.28e-08!24;UBERON:0001557!2.28e-08!24;UBERON:0001042!2.28e-08!24;UBERON:0008814!2.28e-08!24;UBERON:0009145!2.28e-08!24;UBERON:0001004!2.42e-08!42;UBERON:0007811!3.42e-08!36;UBERON:0000475!4.52e-08!150;UBERON:0000072!7.14e-08!27;UBERON:0002390!1.30e-07!45;UBERON:0003061!1.30e-07!45;UBERON:0001041!2.12e-07!80;UBERON:0002193!4.90e-07!48;UBERON:0002405!4.90e-07!48
|ontology_enrichment_uberon=UBERON:0004177!7.47e-11!29;UBERON:0005057!7.47e-11!29;UBERON:0000153!3.20e-10!43;UBERON:0002370!4.62e-09!23;UBERON:0000974!4.62e-09!23;UBERON:0004807!4.62e-09!23;UBERON:0005058!4.62e-09!23;UBERON:0003351!4.62e-09!23;UBERON:0009113!4.62e-09!23;UBERON:0003295!4.62e-09!23;UBERON:0009722!4.62e-09!23;UBERON:0005562!4.62e-09!23;UBERON:0007690!4.62e-09!23;UBERON:0000065!1.12e-08!41;UBERON:0000077!1.26e-08!35;UBERON:0003408!1.59e-08!24;UBERON:0006562!2.28e-08!24;UBERON:0001557!2.28e-08!24;UBERON:0001042!2.28e-08!24;UBERON:0008814!2.28e-08!24;UBERON:0009145!2.28e-08!24;UBERON:0001004!2.42e-08!42;UBERON:0007811!3.42e-08!36;UBERON:0000475!4.52e-08!150;UBERON:0000072!7.14e-08!27;UBERON:0002390!1.30e-07!45;UBERON:0003061!1.30e-07!45;UBERON:0001041!2.12e-07!80;UBERON:0002193!4.90e-07!48;UBERON:0002405!4.90e-07!48
|tfbs_overrepresentation_for_novel_motifs=0.641384,1.30284,0.612053,0.688265,0.483253,0.704257,0.803568,0.370124,0.381467,0.162942,0.755749,0.790506,0.37041,0.81685,0.502646,0,1.02248,0.473993,0.352304,0.683591,0.570433,0.57409,0.815872,0.481455,1.50428,0.846564,0.342316,0.727368,1.32554,0.290745,0.711848,1.12823,2.06579,0.318879,0.503207,0.30022,1.16474,0.786577,0.434783,1.03515,0.478558,0.717547,0.185353,0.504971,0.325217,0.675898,0.938241,0.744678,0.162985,0.539131,1.0041,0.875451,0.282443,1.2746,1.29252,0.82458,0.549352,0.776619,0.331485,0.822375,1.10737,0.885556,0.39557,0.992216,0.8366,1.03484,1.43193,1.78579,1.1025,1.63712,0.590754,0.98374,1.12016,1.32691,2.36634,0.834514,0.318792,0.926147,1.08947,1.40903,0.37865,1.04072,0.884013,0.362446,1.20828,2.44772,0.129654,0.290918,0.943446,1.94914,1.50286,1.21342,1.14153,0.490141,0.430015,0.409166,0.367176,1.14445,0.938512,0.264911,0.460566,1.12793,1.25667,1.00472,1.00361,1.70541,1.06633,0.740267,0.580757,0.57247,0.633483,1.25851,1.41174,0.7614,1.51002,0.476467,1.40021,0.692434,1.02384,0.456123,1.33244,0.970073,0.848526,0.925183,1.56496,1.09333,0.812403,1.13449,1.43038,0.493609,1.23918,0.680176,1.40022,0.839311,1.53196,0.569254,0.650785,0.719099,1.482,2.31884,1.91709,1.43673,0.861473,1.1391,0.996781,0.718046,0.941555,2.27909,0.653418,0.485304,0.293812,1.63788,1.27621,1.069,0.838313,1.35996,0.87653,0.516549,0.63863,0.650472,1.49167,1.20739,1.09379,0.630949,0.993294,0.830321,0.459159,0.788782,0.589293
}}
}}

Revision as of 21:17, 26 November 2012


Phase1 CAGE Peaks

 Short description
Mm9::chr2:53050229..53050243,-p2@Prpf40a
Mm9::chr3:152058955..152059023,+p1@Gm8261
p1@Zzz3
Mm9::chr3:157694669..157694738,-p2@Srsf11
Mm9::chr5:52581723..52581763,-p1@Dhx15


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


GO IDGO nameFDR corrected p-value
GO:0008380RNA splicing0.00250756890761273
GO:0006397mRNA processing0.00250756890761273
GO:0016071mRNA metabolic process0.00250756890761273
GO:0006396RNA processing0.00351370644610112
GO:0003724RNA helicase activity0.0119608953170559



Relative expression of the co-expression cluster over median <br>Analyst:





Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>


Cell Type
Ontology termp-valuen
lymphocyte3.48e-0913
common lymphoid progenitor3.48e-0913
lymphoid lineage restricted progenitor cell1.08e-0812
T cell4.83e-0811
pro-T cell4.83e-0811
mature alpha-beta T cell4.25e-079
alpha-beta T cell4.25e-079
immature T cell4.25e-079
mature T cell4.25e-079
immature alpha-beta T cell4.25e-079

Uber Anatomy
Ontology termp-valuen
hemopoietic organ7.47e-1129
immune organ7.47e-1129
anterior region of body3.20e-1043
thymus4.62e-0923
neck4.62e-0923
respiratory system epithelium4.62e-0923
hemolymphoid system gland4.62e-0923
pharyngeal epithelium4.62e-0923
thymic region4.62e-0923
pharyngeal gland4.62e-0923
entire pharyngeal arch endoderm4.62e-0923
thymus primordium4.62e-0923
early pharyngeal endoderm4.62e-0923
respiratory tract1.12e-0841
mixed endoderm/mesoderm-derived structure1.26e-0835
gland of gut1.59e-0824
pharynx2.28e-0824
upper respiratory tract2.28e-0824
chordate pharynx2.28e-0824
pharyngeal arch system2.28e-0824
pharyngeal region of foregut2.28e-0824
respiratory system2.42e-0842
craniocervical region3.42e-0836
organism subdivision4.52e-08150
segment of respiratory tract7.14e-0827
hematopoietic system1.30e-0745
blood island1.30e-0745
foregut2.12e-0780
hemolymphoid system4.90e-0748
immune system4.90e-0748


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}